Literature DB >> 25155047

Expression of p8 in Human Oral Squamous Cell Carcinoma.

Christopher Bingham1, Douglas Dickinson, James Cray, Komal Koli, Kalu U E Ogbureke.   

Abstract

The present study investigated the expression of p8, a transcription factor upregulated in some human cancers, in oral squamous cell carcinomas (OSCCs). Immunohistochemical analysis of p8 expression was carried out on 20 archived surgical specimens of human OSCCs, and expression correlated with clinical outcome parameters in a retrospective study. Expression of p8 in a number of OSCC cell lines also was investigated by western blot and RT-PCR analyses. p8 was expressed in 80 % (16/20) of the samples with levels of expression exhibiting a significant difference (χ(2) = 8.352, df = 3, p = 0.039) by patient age. Furthermore, greater levels of p8 immunoreactivity was significantly associated with advanced tumor grade (p = 0.008). p8 also was upregulated in OSCC cell lines. p8 is expressed in a significant proportion of OSCCs, and in human OSCC cell lines, suggesting a potential value of p8 as a diagnostic and/prognostic tool for oral cancers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25155047      PMCID: PMC4424217          DOI: 10.1007/s12105-014-0565-1

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  22 in total

1.  Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture.

Authors:  A Gasparoni; L Fonzi; G B Schneider; P W Wertz; G K Johnson; C A Squier
Journal:  Arch Oral Biol       Date:  2004-08       Impact factor: 2.633

2.  Expression of a novel factor in human breast cancer cells with metastatic potential.

Authors:  A H Ree; M Tvermyr; O Engebraaten; M Rooman; O Røsok; E Hovig; L A Meza-Zepeda; O S Bruland; O Fodstad
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

3.  Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth.

Authors:  G V Mallo; F Fiedler; E L Calvo; E M Ortiz; S Vasseur; V Keim; J Morisset; J L Iovanna
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

4.  Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy.

Authors:  Sandro Goruppi; Joseph V Bonventre; John M Kyriakis
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

5.  Expression of a novel factor, com1, in early tumor progression of breast cancer.

Authors:  A H Ree; M M Pacheco; M Tvermyr; O Fodstad; M M Brentani
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

6.  Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14.

Authors:  Stephen Hsu; Tetsuya Yamamoto; James Borke; Douglas S Walsh; Baldev Singh; Sushma Rao; Kamatani Takaaki; Nam Nah-Do; Carol Lapp; David Lapp; Emily Foster; Wendy B Bollag; Jill Lewis; John Wataha; Tokio Osaki; George Schuster
Journal:  J Pharmacol Exp Ther       Date:  2004-11-10       Impact factor: 4.030

7.  Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.

Authors:  F Courjal; C Theillet
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

8.  Structural and functional characterization of the mouse p8 gene: promotion of transcription by the CAAT-enhancer binding protein alpha (C/EBPalpha) and C/EBPbeta trans-acting factors involves a C/EBP cis-acting element and other regions of the promoter.

Authors:  S Vasseur; G V Mallo; A Garcia-Montero; E M Ortiz; F Fiedler; E Cánepa; S Moreno; J L Iovanna
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

9.  Reexpression of p8 contributes to tumorigenic properties of pituitary cells and appears in a subset of prolactinomas in transgenic mice that hypersecrete luteinizing hormone.

Authors:  Helai P Mohammad; Darcie D Seachrist; Christine C Quirk; John H Nilson
Journal:  Mol Endocrinol       Date:  2004-07-08

10.  DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype.

Authors:  S E Chang; S Foster; D Betts; W E Marnock
Journal:  Int J Cancer       Date:  1992-12-02       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.